Crystal Crop Protection IPO opens on November 18; GMP at ₹19. Check price band, lot size
Crystal Crop Protection's ₹455.49-crore IPO will remain open for subscription from November 18 to November 20. The company has raised nearly ₹136 crore from anchor investors, with WhiteOak Capital Mutual Fund and Tata Mutual Fund emerging as the largest participants.

The initial public offering of agrochemicals company Crystal Crop Protection will open for subscription on Wednesday, November 18. The ₹455.49-crore public issue will close on November 20.Ahead of the issue opening, the company has raised nearly ₹136 crore from anchor investors.WhiteOak Capital Mutual Fund emerged as the largest investor in the anchor book, subscribing to 11.02 lakh shares worth ₹30 crore through four schemes. Tata Mutual Fund followed, acquiring 9.22 lakh shares worth ₹25.1 crore through three schemes.International Finance Corporation , which withdrew its name from the offer-for-sale portion, also increased its stake in Crystal Crop Protection by purchasing an additional 7.35 lakh shares worth ₹20 crore.IFC and its subsidiary, IFC Emerging Asia Fund, held a combined stake of 8.29% in the company, while WhiteOak Capital acquired a 1.03% stake in the pre-IPO round.Ashoka India Equity Investment Trust, Groww Mutual Fund, Neo, Nomura Singapore and Citigroup were among the other investors that participated in the anchor book.Crystal Crop Protection has fixed the IPO price band at ₹259-272 per equity share.
The lot size is 55 shares, and investors can bid in multiples of this lot size.At the upper end of the price band, retail investors will need a minimum investment of ₹14,960 to apply for one lot, excluding applicable charges. The company is seeking a valuation of approximately ₹4,438 crore at the upper end of the price band.Ahead of the issue opening, the grey market premium of Crystal Crop Protection stood at ₹19.However, the GMP is an unofficial indicator of investor sentiment and does not guarantee listing gains. It can fluctuate depending on market conditions and should not be considered a reliable prediction of the actual listing price.The IPO comprises a fresh issue of equity shares worth up to ₹354.77 crore and an offer for sale of 37.03 lakh equity shares aggregating to approximately ₹100.71 crore.While the proceeds from the fresh issue will go to the company, the OFS will allow promoter Ankur Aggarwal to sell part of his shareholding.
The proceeds from this portion will go to the selling shareholder rather than Crystal Crop Protection.The company plans to use the proceeds from the fresh issue primarily to repay or prepay certain outstanding borrowings of the company and its material subsidiary, Saffire Crop Science. The funds will also be deployed towards inorganic growth through acquisitions, strategic initiatives and general corporate purposes.The IPO has reserved 50% of the net offer for qualified institutional buyers , 35% for retail individual investors and 15% for non-institutional investors .Established in 1994, Crystal Crop Protection is an agricultural solutions company headquartered in New Delhi. Its business portfolio spans crop protection products, seeds and other agricultural solutions.The company manufactures and markets a range of crop protection products, including herbicides, fungicides and insecticides.
Its portfolio also includes natural crop solutions such as bio-protectants, bio-stimulants, liquid fertilisers, plant growth regulators and micronutrients.Additionally, Crystal Crop Protection offers seeds for field crops, vegetables and flowers, catering to a range of agricultural requirements.The basis of allotment is expected to be finalised on November 23. Refunds and the credit of shares to successful applicants' demat accounts are scheduled for November 25.Shares of Crystal Crop Protection are tentatively scheduled to list on the BSE and the National Stock Exchange on November 26.
Related Stories

Anthropic shares set for Nasdaq debut today; Wall Street brokerages see up to 87% upside from IPO price: Report
Four brokerages issued bullish ratings, with price targets implying potential gains of 51% to 87%, citing growth prospects and rising AI adoption.
European shares rebound as Anthropic IPO boosts tech stocks; Commerzbank rallies
European equities recovered on Thursday, snapping a three-day losing streak as chipmakers and tech shares surged ahead of Anthropic's record $81.3 billion Nasdaq debut. Banking stocks also lent support, with Commerzbank and UniCredit advancing after reaching a key breakthrough with Berlin over their proposed takeover deal, offsetting losses in pharma major Novartis.
Fed flags financial stability risks from AI investment boom, elevated asset valuations
The US Federal Reserve has flagged financial stability risks from the AI investment boom, elevated asset valuations and rising hedge fund leverage. Policymakers warned that disappointing returns on AI investments, heavy borrowing and concentrated market exposure could trigger broader financial disruptions, even as banks and households remain relatively resilient.